BCL11B and hepatocellular carcinoma: Our results indicated that overexpression of BCL11B amplifies GATA6 expression in HCC in vitro and in vivo, leads to anti‐apoptotic signal activation, and induces resistance to anthracycline used in chemotherapy for HCC, which influenced the postoperative prognosis.